These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 37700834)

  • 21. The Clinical Significance and Functional Role of miR-466 in Gastric Cancer Peritoneal Metastasis.
    Wang Y; Yan B; Ni L; Si Y; Cao P
    Mol Biotechnol; 2022 Jan; 64(1):25-32. PubMed ID: 34435325
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Predicting postoperative peritoneal metastasis in gastric cancer with serosal invasion using a collagen nomogram.
    Chen D; Liu Z; Liu W; Fu M; Jiang W; Xu S; Wang G; Chen F; Lu J; Chen H; Dong X; Li G; Chen G; Zhuo S; Yan J
    Nat Commun; 2021 Jan; 12(1):179. PubMed ID: 33420057
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT.
    Shi B; Lin H; Zhang M; Lu W; Qu Y; Zhang H
    J Vis Exp; 2018 Jan; (131):. PubMed ID: 29443079
    [TBL] [Abstract][Full Text] [Related]  

  • 24. C-C motif chemokine 22 ligand (CCL22) concentrations in sera of gastric cancer patients are related to peritoneal metastasis and predict recurrence within one year after radical gastrectomy.
    Wei Y; Wang T; Song H; Tian L; Lyu G; Zhao L; Xue Y
    J Surg Res; 2017 May; 211():266-278. PubMed ID: 28501127
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of urokinase-type plasminogen activator system in gastric cancer with peritoneal metastasis.
    Ding Y; Zhang H; Lu A; Zhou Z; Zhong M; Shen D; Wang X; Zhu Z
    Oncol Lett; 2016 Jun; 11(6):4208-4216. PubMed ID: 27313768
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A Case of Peritoneal Dissemination and Splenic Metastasis after Gastric Cancer Surgery That Could Be Controlled with Multidisciplinary Treatment.
    Karakuchi N; Yanagawa S; Takei D; Kodama S; Takeshima Y; Sumimoto K
    Case Rep Oncol; 2020; 13(3):1164-1170. PubMed ID: 33173480
    [TBL] [Abstract][Full Text] [Related]  

  • 27. FMO family may serve as novel marker and potential therapeutic target for the peritoneal metastasis in gastric cancer.
    Gong X; Hou D; Zhou S; Tan J; Zhong G; Yang B; Xie L; Han F; Zhong L
    Front Oncol; 2023; 13():1144775. PubMed ID: 37274237
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The tumor immune microenvironment in peritoneal carcinomatosis.
    Demuytere J; Ernst S; van Ovost J; Cosyns S; Ceelen W
    Int Rev Cell Mol Biol; 2022; 371():63-95. PubMed ID: 35965001
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Troponin I2 as a Specific Biomarker for Prediction of Peritoneal Metastasis in Gastric Cancer.
    Sawaki K; Kanda M; Miwa T; Umeda S; Tanaka H; Tanaka C; Kobayashi D; Suenaga M; Hattori N; Hayashi M; Yamada S; Nakayama G; Fujiwara M; Kodera Y
    Ann Surg Oncol; 2018 Jul; 25(7):2083-2090. PubMed ID: 29663169
    [TBL] [Abstract][Full Text] [Related]  

  • 30. u-PA inhibitor amiloride suppresses peritoneal metastasis in gastric cancer.
    Ding Y; Zhang H; Zhou Z; Zhong M; Chen Q; Wang X; Zhu Z
    World J Surg Oncol; 2012 Dec; 10():270. PubMed ID: 23234499
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Activated Leukocyte Cell Adhesion Molecule (ALCAM), a Potential 'Seed' and 'Soil' Receptor in the Peritoneal Metastasis of Gastrointestinal Cancers.
    Yang YM; Ye L; Ruge F; Fang Z; Ji K; Sanders AJ; Jia S; Hao C; Dou QP; Ji J; Jiang WG
    Int J Mol Sci; 2023 Jan; 24(1):. PubMed ID: 36614319
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comprehensive Analysis of Peritoneal Metastasis Sequencing Data to Identify LINC00924 as a Prognostic Biomarker in Gastric Cancer.
    Fang Y; Huang S; Han L; Wang S; Xiong B
    Cancer Manag Res; 2021; 13():5599-5611. PubMed ID: 34285580
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Laparoscopic diagnosis of postoperative recurrence of peritoneal metastasis in gastric cancer patients and the clinical efficacy of bidirectional intraperitoneal and systemic chemotherapy].
    Yan C; Yang ZY; Shi M; Xu W; Ni ZT; Hua ZC; Liu WT; Zhu ZL; Bi RD; Zheng YN; Feng RH; Yao XX; Chen MM; Li C; Zhang J; Yan M; Zhu ZG
    Zhonghua Wei Chang Wai Ke Za Zhi; 2020 May; 23(5):492-498. PubMed ID: 32842430
    [No Abstract]   [Full Text] [Related]  

  • 34. The Value of Serum Immunoglobulin G Glycome in the Preoperative Discrimination of Peritoneal Metastasis from Advanced Gastric Cancer.
    Qin R; Yang Y; Qin W; Han J; Chen H; Zhao J; Zhao R; Li C; Gu Y; Pan Y; Wang X; Ren S; Sun Y; Gu J
    J Cancer; 2019; 10(12):2811-2821. PubMed ID: 31258789
    [No Abstract]   [Full Text] [Related]  

  • 35. A self-enforcing HOXA11/Stat3 feedback loop promotes stemness properties and peritoneal metastasis in gastric cancer cells.
    Wang C; Shi M; Ji J; Cai Q; Jiang J; Zhang H; Zhu Z; Zhang J
    Theranostics; 2019; 9(25):7628-7647. PubMed ID: 31695791
    [No Abstract]   [Full Text] [Related]  

  • 36. Removal of small extracellular vesicles inhibits the progression of peritoneal dissemination in gastric cancer.
    Shibamoto J; Arita T; Konishi H; Kataoka S; Furuke H; Takaki W; Takabatake K; Kiuchi J; Ohashi T; Shimizu H; Yamamoto Y; Komatsu S; Shiozaki A; Kubota T; Okamoto K; Otsuji E
    Gastric Cancer; 2022 Jul; 25(4):712-725. PubMed ID: 35368210
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Phase 1 Study of Combined Chemotherapy of Nab-Paclitaxel, S-1, and Oxaliplatin for Gastric Cancer with Peritoneal Metastasis (NSOX Study).
    Nakamura M; Ojima T; Katsuda M; Hayata K; Kitadani J; Nakamori M; Yamaue H
    Oncology; 2021; 99(1):57-61. PubMed ID: 32877909
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tumor microenvironment in ovarian cancer peritoneal metastasis.
    Mei S; Chen X; Wang K; Chen Y
    Cancer Cell Int; 2023 Jan; 23(1):11. PubMed ID: 36698173
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibitory effects of a specific phage-displayed peptide on high peritoneal metastasis of gastric cancer.
    Bai F; Liang J; Wang J; Shi Y; Zhang K; Liang S; Hong L; Zhai H; Lu Y; Han Y; Yin F; Wu K; Fan D
    J Mol Med (Berl); 2007 Feb; 85(2):169-80. PubMed ID: 17043801
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High CD8/CD33 ratio in peritoneal metastatic lesions is associated with favorable prognosis in gastric cancer.
    Yamaguchi T; Kinoshita J; Saito H; Shimada M; Terai S; Moriyama H; Okamoto K; Makino I; Nakamura K; Tajima H; Ninomiya I; Fushida S
    Cancer Rep (Hoboken); 2021 Oct; 4(5):e1389. PubMed ID: 33793095
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.